These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24685074)

  • 1. Erythropoietin modulates imbalance of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in doxorubicin-induced cardiotoxicity.
    Chen X; Guo Z; Wang P; Xu M
    Heart Lung Circ; 2014 Aug; 23(8):772-7. PubMed ID: 24685074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity.
    Hydock DS; Lien CY; Jensen BT; Parry TL; Schneider CM; Hayward R
    Exp Biol Med (Maywood); 2012 Dec; 237(12):1483-92. PubMed ID: 23354407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy.
    Chen X; Chen Y; Bi Y; Fu N; Shan C; Wang S; Aslam S; Wang PW; Xu J
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):367-74. PubMed ID: 17924179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to protect doxorubicin-induced cardiomyopathy in male albino rats?
    Shaker O; Sourour DA
    J Cardiovasc Pharmacol; 2010 Mar; 55(3):262-8. PubMed ID: 20051877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
    An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
    Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats.
    Ammar el-SM; Said SA; Suddek GM; El-Damarawy SL
    Can J Physiol Pharmacol; 2011 Apr; 89(4):269-76. PubMed ID: 21526973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy.
    Hamed S; Barshack I; Luboshits G; Wexler D; Deutsch V; Keren G; George J
    Eur Heart J; 2006 Aug; 27(15):1876-83. PubMed ID: 16731534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats.
    Ammar el-SM; Said SA; El-Damarawy SL; Suddek GM
    Pharm Biol; 2013 Mar; 51(3):339-44. PubMed ID: 23134235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicin.
    Segredo MP; Salvadori DM; Rocha NS; Moretto FC; Correa CR; Camargo EA; de Almeida DC; Reis RA; Freire CM; Braz MG; Tang G; Matsubara LS; Matsubara BB; Yeum KJ; Ferreira AL
    Hum Exp Toxicol; 2014 Jul; 33(7):748-60. PubMed ID: 24275640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study.
    Saeed NM; El-Naga RN; El-Bakly WM; Abdel-Rahman HM; Salah ElDin RA; El-Demerdash E
    Biochem Pharmacol; 2015 Jun; 95(3):145-55. PubMed ID: 25701654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
    Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
    Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity.
    Ludke AR; Al-Shudiefat AA; Dhingra S; Jassal DS; Singal PK
    Can J Physiol Pharmacol; 2009 Oct; 87(10):756-63. PubMed ID: 19898559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity.
    Ferreira A; Cunha-Oliveira T; Simões RF; Carvalho FS; Burgeiro A; Nordgren K; Wallace KB; Oliveira PJ
    Toxicology; 2017 Sep; 390():63-73. PubMed ID: 28865727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation.
    Richard C; Ghibu S; Delemasure-Chalumeau S; Guilland JC; Des Rosiers C; Zeller M; Cottin Y; Rochette L; Vergely C
    J Pharmacol Exp Ther; 2011 Dec; 339(3):807-14. PubMed ID: 21934029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB; Li DG; Lu HM
    J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamic evolution of MMP-2 gene expression and its enzymatic activities in experimental liver fibrosis].
    Zhu YK; Wang BE; Shen FJ; Jia JD; Ma H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):509-12. PubMed ID: 16042886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.